Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Introducing Cytiva: GE plans name change ahead of $21bn Danaher buy - BioProcess International
Introducing Cytiva: GE plans name change ahead of $21bn Danaher buy BioProcess International
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems - BioProcess International
Filling in its drug product offering: Cytiva buys Vanrx Pharmasystems BioProcess International
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page